AMLX
Amylyx Pharmaceuticals Inc

2,188
Loading...
Loading...
Amylyx Pharmaceuticals, Inc. is a commercial-stage biotechnology company, which engages in the provision of therapies for neurodegenerative diseases and amyotrophic lateral sclerosis (ALS). Its commercial product is Relyvrio, also known as Albrioza in Canada. The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
123

Frequently Asked Questions

What is Market Cap of Amylyx Pharmaceuticals Inc?
What is the 52-week high for Amylyx Pharmaceuticals Inc?
What is the 52-week low for Amylyx Pharmaceuticals Inc?
What is Amylyx Pharmaceuticals Inc stock price today?
What was Amylyx Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Amylyx Pharmaceuticals Inc?
What is the Price-to-Book ratio of Amylyx Pharmaceuticals Inc?
What is the 50-day moving average of Amylyx Pharmaceuticals Inc?
How many employess does Amylyx Pharmaceuticals Inc has?

Latest AMLX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.